Science Explorer Back to mapMap
Discussion
Researcher · New York University · United States

Allal Boutajangout

Allal Boutajangout publishes mostly in Physiology, Neurology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms and Cholinesterase and Neurodegenerative Diseases.

OpenAlex
World rank
#1,647,512
of 7,710,434 ranked researchers
Rank in United States
#511,118
of 1,627,098
Works
50
Citations
2k
Citations per work
40.3
h-index
19
i10-index 21Top 27% in Physiology (Medicine)
Allal Boutajangout

What does Allal Boutajangout research?

Allal Boutajangout's work is mostly in Medicine (39%), Neuroscience (26%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 20 works · 39.4% of their workMedicine: 20 works · 39.4% of their workPhysiology: 16 works · 32.8% of their workPharmacology: 3 works · 6.6% of their workLife Sciences: 18 works · 35.7% of their workNeuroscience: 13 works · 26.2% of their workNeurology: 8 works · 15.3% of their workCellular and Molecular Neuroscience: 3 works · 5.8% of their workBiological Psychiatry: 3 works · 5.1% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 9.5% of their workMolecular Biology: 5 works · 9.5% of their workEverything else: 12 works · 24.9% of their workTHEIR WORKAllalBoutajangout50works
Life Sciences36%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2039.4%
    1. Neuroscience1326.2%
    2. Biochemistry, Genetics and Molecular Biology59.5%
  3. Everything else1224.9%
  1. 1Physiology33% of their works
  2. 2Neurology15% of their works
  3. 3Molecular Biology10% of their works
  4. 4Pharmacology7% of their works
  5. 5Cellular and Molecular Neuroscience6% of their works
  6. 6Biological Psychiatry5% of their works

Research topics

Which keywords describe Allal Boutajangout's research?

The keywords of their largest research topics: Neuroinflammation, Neurodegeneration, Oxidative Stress, Amyloid Hypothesis, Tau Pathology, Cytokines, Microglia and Astrocytes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Neuroinflammation703 topics
  2. Neurodegeneration632 topics
  3. Oxidative Stress502 topics
  4. Amyloid Hypothesis431 topic
  5. Tau Pathology431 topic
  6. Cytokines272 topics
  7. Microglia272 topics
  8. Astrocytes201 topic
  9. Synaptic Pruning201 topic
  10. Neurodegenerative Diseases152 topics
  11. Acetylcholinesterase91 topic
  12. Cholinesterase Inhibitors91 topic
  13. Depression71 topic
  14. Tryptophan Metabolism71 topic
  15. Molecular Basis61 topic
  16. Prion Diseases61 topic
  17. Molecular Docking51 topic
  18. Virtual Screening51 topic
  19. Neurologic Manifestations41 topic
  20. Neurotransmission41 topic
  21. Post-acute COVID-19 Syndrome41 topic
  22. Synaptic Plasticity41 topic

Where does Allal Boutajangout work?

Allal Boutajangout's main affiliation in the publication record is New York University, United States.

How many publications and citations does Allal Boutajangout have?

OpenAlex counts 50 works and 2,017 citations for Allal Boutajangout, an h-index of 19, ranking #1,647,512 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Allal Boutajangout

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Allal Boutajangout. Posts are plain text and can be reported.